The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- N/A
A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)
- Status
- UNKNOWN
- Phase
- NA
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE1
Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Extension Trial of Repeated Infusions of ISF35
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
- Status
- COMPLETED
- Phase
- PHASE1
Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL
- Status
- COMPLETED
- Phase
- PHASE1